# Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.

> **NCT00521170** · PHASE1 · COMPLETED · sponsor: **UCB Pharma**

## Conditions studied

- Allergy

## Interventions

- **DRUG:** Levocetirizine

## Key facts

- **NCT ID:** NCT00521170
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521170, "Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00521170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*